Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy Testing
Colorimetric microarray assay for allergen-responsive IgE developed
August 15th, 2005
A novel colorimetric microarray assay enables high-throughput, accurate screening for allergen susceptibility. "With the existence of several thousand unique human allergens, a multiplex format, such as protein microarrays, is an attractive option for allergy screening," immunologists in California explained. "To determine the feasibility and sensitivity of using an enzyme-based, colorimetric protein microarray assay, three common allergens (mold, dustmite, grass) were arrayed and added sera assayed for responsive human IgE," in a study conducted by S.J. Lebrun and coauthors working at Anaheim-based Miragene, Inc. "Normal, low...
Source: Pharma Business Week (2005-08-15)
|
